Latest Breaking News On - 000 employees work to makea positive difference millions of people 39s lives every day by creating more joyful and sustainable ways live from advancing gene editing technologies discovering unique treat the most challenging diseases enabling intelligence devices company is everywhere in 2021 - Page 1 : comparemela.com
A long-term, strategic, enterprise-level technology collaboration aims tofurther increase production efficiencies and reduce costs for Micron and its suppliers CAMBRIDGE, Mass., July 19, 2022 /PRNewswire/ Today, Athiniaannounced that Micron Technology, Inc. (Nasdaq: MU), a global leader in innovative memory and storage solutions, plans to use the Athinia data analytics platform to create a pioneering data collaboration ecosystem that will help lead a continued journey of digital transformation with Micron's critical suppliers. Athinia's state-of-the-art AI-driven quality control methodology will be able to further improve process and device yield, reduce costs and accelerate time to value generation using select data and insights from Micron's supply chain. Athinia, launched in December 2021, is a partnership between Merck (DAX:MKGAF) and Palantir Technologies Inc. (NYSE:PLTR). "The secure architecture provided by Athinia will allow Micron and its suppliers to share
Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing Selected startups can receive funding of up to 100,000 SHANGHAI, July 14, 2022 /PRNewswire/ Merck, a leading science and technology company, today announced the launch of its Uptune program in Asia, which aims to generate collaboration opportunities with early-stage innovative companies. "The startup environment in Asia is unique and inspiring. Building mutually beneficial and sustainable partnerships with promising startups and creating synergies between Merck and young companies will bring forward the next big ideas." said Steven Johnston, Vice President, Head of Technology Innovation and Enablement, Merck Group Science and Technology Office. "Merck can be a strong supporter for them to jointly grow their business, providing not only funding, but also knowledg
Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry's largest manufacturers of these components globally Builds on company's 30 years' CDMO experience with multi-step, complex, and highly potent compounds DARMSTADT, Germany, June 23, 2022 /PRNewswire/ Merck, a leading science and technology company, announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new 59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area. "There is an increasing demand for HPAPIs due to their effectiveness against cancer at lower doses and the trend towards more targeted therapeutics. Lower-doses of these therapies reduce the negative side effects for patients who are taking on this critical fight," said Dirk Lange,